Redmile Group’s Xeris Biopharma Holdings XERS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.11M	Hold	451,099	–	–	0.22%	42
2025 Q1	$2.48M	Hold	451,099	–	–	0.23%	48
2024 Q4	$1.53M	Sell	451,099 -595,488	-57%	-$2.02M	0.11%	57
2024 Q3	$2.98M	Hold	1,046,587	–	–	0.18%	54
2024 Q2	$2.35M	Hold	1,046,587	–	–	0.14%	56
2024 Q1	$2.31M	Hold	1,046,587	–	–	0.08%	71
2023 Q4	$2.46M	Hold	1,046,587	–	–	0.09%	61
2023 Q3	$1.95M	Hold	1,046,587	–	–	0.09%	60
2023 Q2	$2.74M	Hold	1,046,587	–	–	0.11%	64
2023 Q1	$1.71M	Hold	1,046,587	–	–	0.07%	68
2022 Q4	$1.39M	Hold	1,046,587	–	–	0.06%	65
2022 Q3	$1.63M	Hold	1,046,587	–	–	0.06%	66
2022 Q2	$1.61M	Hold	1,046,587	–	–	0.06%	66
2022 Q1	$2.68M	Hold	1,046,587	–	–	0.08%	64
2021 Q4	$3.07M	Sell	1,046,587 -312,238	-23%	-$915K	0.07%	66
2021 Q3	$3.33M	Hold	1,358,825	–	–	0.06%	71
2021 Q2	$5.53M	Sell	1,358,825 -353,479	-21%	-$1.44M	0.08%	79
2021 Q1	$7.72M	Sell	1,712,304 -685,137	-29%	-$3.09M	0.11%	77
2020 Q4	$11.8M	Hold	2,397,441	–	–	0.14%	71
2020 Q3	$14.2M	Hold	2,397,441	–	–	0.26%	62
2020 Q2	$6.38M	Sell	2,397,441 -560,000	-19%	-$1.49M	0.12%	72
2020 Q1	$5.77M	Sell	2,957,441 -43,200	-1%	-$84.2K	0.16%	59
2019 Q4	$21.2M	Hold	3,000,641	–	–	0.51%	48
2019 Q3	$29.5M	Hold	3,000,641	–	–	0.99%	31
2019 Q2	$34.3M	Hold	3,000,641	–	–	0.97%	31
2019 Q1	$30.1M	Buy	3,000,641 +588,000	+24%	+$5.9M	0.88%	39
2018 Q4	$41M	Buy	2,412,641 +1	+0%	+$17	1.65%	20
2018 Q3	$42.4M	Sell	2,412,640 -2	-0%	-$35	1.3%	27
2018 Q2	$45.8M	Buy	+2,412,642	New	+$45.8M	1.56%	24